Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
2.150
+0.040 (1.90%)
At close: Jan 22, 2026, 4:00 PM EST
2.120
-0.030 (-1.40%)
After-hours: Jan 22, 2026, 7:42 PM EST
Silexion Therapeutics Market Cap
Silexion Therapeutics has a market cap or net worth of $6.72 million as of January 22, 2026. Its market cap has increased by 95.04% in one year.
Market Cap
6.72M
Enterprise Value
-495.72K
1-Year Change
95.04%
Ranking
Category
Stock Price
$2.15
Market Cap Chart
Since April 7, 2021, Silexion Therapeutics's market cap has decreased from $148.55M to $6.72M, a decrease of -95.47%. That is a compound annual growth rate of -47.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 6.60M | 9.90% |
| Dec 31, 2025 | 6.00M | 86.31% |
| Dec 31, 2024 | 3.22M | -92.33% |
| Dec 21, 2023 | 41.99M | -71.93% |
| Dec 30, 2022 | 149.59M | 4.03% |
| Dec 31, 2021 | 143.80M | -3.20% |
| Apr 7, 2021 | 148.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 289.32B |
| Novartis AG | 278.23B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 261.50B |